These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3030696)

  • 21. Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo.
    Huang LC; Fonteles MC; Houston DB; Zhang C; Larner J
    Endocrinology; 1993 Feb; 132(2):652-7. PubMed ID: 8425485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abolition of the expression of inhibitory guanine nucleotide regulatory protein Gi activity in diabetes.
    Gawler D; Milligan G; Spiegel AM; Unson CG; Houslay MD
    Nature; 1987 May 21-27; 327(6119):229-32. PubMed ID: 3106832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenylate cyclase-modulating mediators of insulin.
    Zhang SR; Yue Y; Xing XQ; Wei TQ; Yao WZ; Han JH
    Sci Sin B; 1988 Jul; 31(7):838-49. PubMed ID: 3059491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandin receptors in NIH 3T3 cells: coupling of one receptor to adenylate cyclase and of a second receptor to phospholipase C.
    Gusovsky F
    Mol Pharmacol; 1991 Nov; 40(5):633-8. PubMed ID: 1658602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GLP-1 effect upon the GPI/IPG system in adipocytes and hepatocytes from diabetic rats.
    Márquez L; González N; Puente J; Valverde L; Villanueva-Peñacarrillo ML
    Diabetes Nutr Metab; 2001 Oct; 14(5):239-44. PubMed ID: 11806463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low level cyclic adenosine 3',5'-monophosphate accumulation analysis of [des-His1, des- Phe6, Glu9] glucagon-NH2 identifies glucagon antagonists from weak partial agonists/antagonists.
    Van Tine BA; Azizeh BY; Trivedi D; Phelps JR; Houslay MD; Johnson DG; Hruby VJ
    Endocrinology; 1996 Aug; 137(8):3316-22. PubMed ID: 8754757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ATP receptor regulation of adenylate cyclase and protein kinase C activity in cultured renal LLC-PK1 cells.
    Anderson RJ; Breckon R; Dixon BS
    J Clin Invest; 1991 May; 87(5):1732-8. PubMed ID: 1850760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for the existence of a sulfhydryl group in the adenylate cyclase active site.
    Skurat AV; Yurkova MS; Baranova LA; Gulyaev NN; Bulargina TV; Severin ES
    Biochem Int; 1985 Mar; 10(3):451-61. PubMed ID: 4015668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coupling of hepatic prostaglandin receptors to adenylate cyclase through a pertussis toxin sensitive guanine nucleotide regulatory protein.
    Garrity MJ; Reed MM; Brass EP
    J Pharmacol Exp Ther; 1989 Mar; 248(3):979-83. PubMed ID: 2539466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple mechanisms of growth inhibition by cyclic AMP derivatives in rat GH1 pituitary cells: isolation of an adenylate cyclase-deficient variant.
    Martin TF; Ronning SA
    J Cell Physiol; 1981 Nov; 109(2):289-97. PubMed ID: 6271795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatostatin inhibits urinary cyclic AMP excretion in diabetic rats.
    Hertelendy F; Calabria D; Todd H; Raab B
    Endocrinology; 1977 Oct; 101(4):1095-8. PubMed ID: 198195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the insulin mediator. II. Separation of two antagonistic biologically active materials from fraction II.
    Cheng K; Galasko G; Huang L; Kellogg J; Larner J
    Diabetes; 1980 Aug; 29(8):659-61. PubMed ID: 6254825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A putative second messenger of insulin action regulates hepatic microsomal glucose-6-phosphatase.
    Suzuki S; Toyota T; Suzuki H; Goto Y
    Biochem Biophys Res Commun; 1984 Jan; 118(1):40-6. PubMed ID: 6320831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of tolbutamide and glyburide on cAMP-dependent protein kinase activity in rat liver cytosol.
    Okuno S; Inaba M; Nishizawa Y; Inoue A; Morii H
    Diabetes; 1988 Jul; 37(7):857-61. PubMed ID: 2838357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partial purification from human mononuclear cells and placental plasma membranes of an insulin mediator which stimulates pyruvate dehydrogenase and suppresses glucose-6-phosphatase.
    Suzuki S; Toyota T; Suzuki H; Goto Y
    Arch Biochem Biophys; 1984 Dec; 235(2):418-26. PubMed ID: 6097186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid conversion by insulin of hepatic intermediary metabolism from glucose production to glucose utilization in the liver of alloxan-diabetic rats.
    Seitz HJ; Müller MJ; Krone W; Tarnowski W
    Diabetes; 1977 Dec; 26(12):1159-74. PubMed ID: 201529
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of cyclic AMP-dependent protein kinase by the polar head group of an insulin-sensitive glycophospholipid.
    Villalba M; Kelly KL; Mato JM
    Biochim Biophys Acta; 1988 Jan; 968(1):69-76. PubMed ID: 3337845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of mediators of insulin action.
    Gottschalk WK; Macaulay SL; Macaulay JO; Kelly K; Smith JA; Jarett L
    Ann N Y Acad Sci; 1986; 488():385-405. PubMed ID: 3034120
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect on lipogenesis and character of mediator induced by insulin and its analogs.
    Wei TQ; Zhang SR
    Sci Sin B; 1988 Jun; 31(6):667-75. PubMed ID: 3079531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin inactivation of rat hepatocyte cyclic AMP-dependent protein kinase.
    Mor MA; Vila J; Ciudad CJ; Guinovart JJ
    FEBS Lett; 1981 Dec; 136(1):131-4. PubMed ID: 6274697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.